MSD

data

The Future of Checkpoint Inhibition in Cancer: Are We About to Challenge the Standard of Care in Triple-Negative Breast Cancer and Gastric and Colorectal Cancers?

Chair: Luis A. Diaz, USA

Welcome and Introductions

18:30 – 18:35

Luis A. Diaz, USA

Tumour Immunology and The Role of Checkpoint Inhibitors

18:35 – 18:55

Luis A. Diaz, USA

The Potential Role of Checkpoint Inhibitors in the Treatment of Colorectal and Gastric Cancers – What is Exciting and What Questions Need to be Addressed

18:55 – 19:15

Markus Möhler, GE

The Emerging Potential of Checkpoint Inhibitors in the Treatment of Breast Cancer

19:15 – 19:35

Michael Untch, GE

Management of Patients Receiving Checkpoint Inhibitors

19:35 – 19:50

Markus Möhler, GE

Discussion and Q&A

14:00 – 14:30

Markus Möhler, GE; Michael Untch, GE

Informação Adicional

  • Data de Início: domingo, 09 outubro 2016
  • Data de Fim: domingo, 09 outubro 2016
  • Horário: 18:30 – 20:00
  • Localidade: Brussels

Simpósio Nacional SPO 2016

Área Reservada

Pesquisa

Os portugueses no ESMO 2016

Dr. Hélder Mansinho

Dr. Miguel Abreu

Prof.ª Doutora Fátima Cardoso

Prof.ª Doutora Fátima Carneiro

Dr. Paulo Cortes

Dr.ª Ana Castro

Dr. Henrique Queiroga

Prof. Doutor António Araújo

Dr.ª Ana Barroso

Dr.ª Encarnação Teixeira

Prof. Doutor Carlos Caldas

Dr. César Martins

Dr. Nuno Couto

Dr.ª Cláudia Vieira

Dr.ª Joana Ribeiro

Dr.ª Mariana Inácio

Dr.ª Rita Sousa

Dr.ª Teresa Amaral

Dr.ª  Ana Coelho

Dr.ª Sofia Braga

Prof. Doutor Ramon de Mello